萬邦德(002082.SZ)擬5.3億元收購萬邦德醫療49%股權
格隆匯3月31日丨萬邦德(002082.SZ)公佈,公司擬使用自有資金5.3億元收購萬邦德醫療科技有限公司(“萬邦德醫療”、“標的公司”)49%股權。收購完成後,萬邦德醫療將成為公司全資子公司。
萬邦德醫療是一家專業從事高端醫療器械研製、醫療設備服務和提供醫院工程服務的新型國際化企業,主要產品及服務包括骨科植入器械、醫療設備及醫院工程服務、醫用高分子製品等。骨科植入器械是人體骨骼替代、修復、補充及充填的一大類植入物的統稱,用於人體骨骼的維持、支撐和修補,是目前臨牀使用較為普遍的骨科醫療材料;醫療設備及醫院工程服務主要包括醫療設備維護、保養,醫院工程服務主要集醫院設計、施工與設備採購、維保於一體的醫院“交鑰匙”工程;醫用高分子無菌醫療器械主要為一次性輸液器系列、注射器系列等產品,包括輸液類輸液器、輸血器、靜脈針;注射類注射器、注射針;配藥類配藥器、配藥針、過濾配藥器;採血類、檢查類等。
此次交易如順利完成,萬邦德醫療將成為公司的全資子公司,有利於公司進一步實施多元化發展戰略,提升公司在醫療器械行業的市場競爭力實現可持續發展,有助於進一步提升企業盈利能力和抗風險能力,實現公司的整體發展戰略和規劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.